10.01 · Audit / Strategy & positioning

The hero says velocity. The proof says exposure.

The site leads with a strong line, then spends the rest of the page leaning on the wrong proof. "Buying media that sells" sets a sales-outcome promise. Most of what follows sells reach, channel breadth, and tenure instead. The first chapter of the audit is about that gap.

THE PROMISE · WHAT THE SITE CLAIMS TO DO

The hero line is the best line on the site.

"BUYING MEDIA THAT SELLS." Six words, sales-outcome, no hedge. It's the right thesis for a tenure-led performance agency, and it's the only place on the site that fully commits to outcome over activity. The sub-headline immediately softens it back to "Total Video Solutions That Drive Results", which is the same line every video-buying shop in the market runs.

Works

"Buying media that sells." Sales-first, no qualifier, owns a clear category position. The kind of line a CFO repeats from memory after one meeting.

Doesn't

"Total Video Solutions That Drive Results" The category, not the position. A CFO would have to look up what Total Video is, and "drive results" is the floor of every agency pitch.

THE PROOF · WHAT THE SITE ACTUALLY SHOWS

Three numbers that don't ladder back to the promise.

The homepage proof strip headlines 37+ years, $2B in stewardship, 40% lower CPMs. Tenure, scale, efficiency. None of them are sales-velocity claims. "Lower CPMs" is a buying-side win, not a sell-side win. To live up to the hero line the proof strip needs at least one metric that finishes the sentence: here is the sale we caused.

HOMEPAGE PROOF CLAIM · CATEGORY · LADDERS TO HERO?
37+ YRS
Tenure proof
Establishes the firm exists and has scale. Does not say what four decades has produced for clients. No ladder back to "media that sells."
$2B+
Stewardship volume
Volume of dollars Diray has placed. A throughput metric, not an outcome metric. The number a CFO is most skeptical of: stewardship vs. ROI.
40%
Lower CPMs
Buying efficiency, not sell-side outcome. Important to a media director, undersells to the CEO the hero line is talking to. CPM is the line item the hero promised to make irrelevant.
10+ YRS
Avg client tenure
The strongest of the four. A 10-year client kept the relationship for a reason. But it's implication, not evidence: the site doesn't name a tenured client and show what compounded.

Tenure, scale, and efficiency are the proofs a buyer expects when the hero line is "we'll lower your CPM." When the hero is "we sell," the proof has to be sales.

10.01 · Strategy & positioning

THE AUDIENCE · WHO THE SITE IS BUILT FOR

Two readers, one page, no separation.

The homepage tries to speak to a performance CMO ("buying media that sells"), an SVP of Media ("40% lower CPMs"), and a brand founder ("scale your brand") in the same scroll. The portfolio confirms the actual book of business is DR-leaning consumer brands (Flex Seal, Pooph, Razor, TIDL, Zevo). That's a clear audience. The site doesn't name it.

  • Implied core audience. DR-style consumer brands ($10M–$500M revenue) selling through Walmart / Target / Amazon, looking for predictable retail lift from TV + streaming + retargeting.
  • Implied secondary. Healthcare / OTC / pharma via Diray Health, which gets a dedicated page but is barely cross-referenced from the main site.
  • Stated audience. "Emerging Brands and Market Challengers" (homepage) — closest the site comes to naming an ICP. Generic, no qualifying numbers attached.
  • What's missing. A clear "this is who we win for, this is who we don't" line. Without it, every visitor self-selects whether they fit, and most won't.

DIFFERENTIATION · WHY DIRAY VS. ALTERNATIVES

The four claims and the one that holds up.

The site offers four implicit answers to "why Diray instead of MNTN, Tatari, Vibe, or a holding-co agency." Three are easy to rebut. One is the actual moat.

CLAIM WHAT THE SITE SAYS · HOW IT HOLDS UP
RATES
"Industry-leading TV advertising rates"
Unverifiable without a benchmark. Every TV buyer claims competitive rates. Weakest of the four.
TECH
"Proprietary MediaINSIGHTS platform"
Named but not shown. No screenshots, no demo path, no description of what decisions it drives. Reads as table stakes, not moat.
CHANNELS
"Total Video" (Linear + CTV + Streaming + YouTube)
Real capability but commoditized framing. Every CTV-first agency now claims the same coverage. The Diray edge here is operational, not strategic.
TENURE
Four decades buying media, 10 years average client
The actual moat. No newer competitor can fake this. The site doesn't lean on it hard enough — tenure is mentioned as a number, not narrated as a capability. What does four decades of buyer relationships actually buy a brand? The site doesn't answer.

SUB-BRAND · DIRAY HEALTH ISN'T LOADED INTO THE MAIN POSITION

A pharma vertical sitting in the navigation, not in the strategy.

Diray Health is a credible specialist play — HIPAA-compliant workflows, IQVIA + LiveRamp + Crossix data integration, NPI / specialty targeting for HCPs, names PureHealth Research, CloSYS, Celltrion, DermTech. The page reads like a focused pharma media practice. Then it goes to die in the nav. The main homepage doesn't mention Diray Health at all. A pharma marketer who lands on the parent site has to discover it as a top-nav item.

On the Diray Health page itself

Clear positioning, named data partners, regulatory cues, real client list. Reads like a category specialist who knows the buyer.

Everywhere else

The parent site does nothing to load the pharma vertical into its positioning. A CMO browsing Diray Media for the first time would not know healthcare is a real practice unless they click the nav.

FINDINGS · FIVE STRATEGIC GAPS

Five things to fix before the next visitor hits the page.

  1. Promise / proof mismatch. Hero says sales, proof shows tenure and CPM. Add at least one sales-velocity metric to the homepage proof strip, even anonymous (e.g., "+18% velocity vs. prior quarter, 12 DMAs, held-out control").
  2. Audience ICP is implicit, not named. Make one sentence on the homepage say "we win for DR-leaning consumer brands selling through Walmart, Target, Amazon, doing $10M–$500M." Loses the buyers who don't fit. Wins the ones who do, faster.
  3. Tenure under-leveraged. four decades and 10-year clients is the moat. Stop showing it as a stat. Narrate it: "the last brand we onboarded had a 6-year contract with a previous agency that left $X on the table." Tenure becomes a story, not a number.
  4. MediaINSIGHTS is unproven on the page. If it's a real differentiator, show three screenshots and one decision it drove. If it's not, stop calling it proprietary and stop treating it as one of the four core claims.
  5. Diray Health needs a parent-site mention. One paragraph + photo on the homepage. Loses no main-line ground, wins the pharma marketer who lands on the wrong page first.